OSTX - OS Therapies Incorporated

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.61 0.05 (3.42%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (-0.3%) 0.02 (1.01%) 0.03 (1.52%) 0.0 (0.0%) 0.03 (1.64%)

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-8.7632
Diluted P/E:
-8.7632
RSI(14) 1m:
50.0
VWAP:
1.67
RVol:

Events

Period Kind Movement Occurred At

Related News